AcelRx Pharmaceuticals Inc expected to post a loss of 6  cents a share - Earnings Preview

Talphera

13/05/2022 15:44

* AcelRx Pharmaceuticals Inc  ACRX.OQ   ACRX.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 16. 
    * The Hayward California-based  company is expected to
report  a
7.6% increase in revenue to $550 thousand from $511 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AcelRx
Pharmaceuticals
Inc is for a loss of 6 cents per share. For the same quarter
last year, the company reported a loss of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $4.25​, above​ its last closing price
of $0.18. ​​​

This summary was machine generated May 13 at 14:44 GMT.  All
figures in US dollars  unless otherwise stated